FindTrial
Sign In

Checking the Survival Status and Cause of Mortality In Patients With Multiple Myeloma

Survival Analysis And Predictors For The Mortality Among Multiple Myeloma Patients - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/059547
Enrollment
350
Registered
2023-11-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C900- Multiple myeloma

Interventions

Intervention1: nil: nil

Sponsors

NITTE (Deemed to be University, NGSM Institute of Pharmaceutical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All the Multiple Myeloma participants above the age of 18 years who were treated from September 2013 to September 2023 in Justice KS Hegde Hospital. Multiple Myeloma participants with clear information about the clinical characteristics and treatment will be incorporated in the study.

Exclusion criteria

Exclusion criteria: participants who dont respond to phone calls will be excluded

Design outcomes

Primary

MeasureTime frame
Time to death is the outcome variable of this study.Timepoint: 6 months (October2023-March 2024)—

Secondary

MeasureTime frame
N/ATimepoint: N/A—

Countries

India

Contacts

Public ContactUday Venkat Mateti

NGSM Institute of Pharmaceutical Sciences.

udayv@nitte.edu.in8152977460

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026